Janux Therapeutics (JANX) Interest Coverage Ratio (2020)

Janux Therapeutics (JANX) has reported Interest Coverage Ratio for 7 consecutive years, with 1.2 the latest figure, recorded in Q1 2026.

• In Q1 2026, Interest Coverage Ratio fell 351.23% year-over-year to 1.2; the TTM figure through Mar 2026 stood at 5.51 (down 536.12% YoY), while the FY2025 annual figure was 5.33, down 1848.8% from the prior year.
• Interest Coverage Ratio slipped to 1.2 in Q1 2026 per JANX's latest filing, from 0.33 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 0.05 in Q2 2024 and bottomed at 53.1 in Q4 2022.
• Historically, Interest Coverage Ratio has averaged 4.22 across 5 years, with a median of 0.46 in 2022.
• Annual changes were most pronounced in 2024 — Interest Coverage Ratio soared 91.5% — and 2025, when it slumped 849.0%.
• Janux Therapeutics' Interest Coverage Ratio stood at 53.1 in 2022, then soared by 98.02% to 1.05 in 2023, then soared by 89.1% to 0.11 in 2024, then slumped by 188.57% to 0.33 in 2025, then tumbled by 263.86% to 1.2 in 2026.
• Business Quant data shows JANX's Interest Coverage Ratio at 1.2 in Q1 2026, 0.33 in Q3 2025, and 0.46 in Q2 2025.